Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jul-24 2:51 PM View:  | Phathom Pharmaceuticals, Inc. (PHAT) | 15-Jul-24 | Sale | 4,325 | $11.72 | $50,689.00 | (4%) 105.68K to 101.36K | |
| 31-May-24 6:37 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 31-May-24 | Grant | 7,500 | -- | -- | 8% 97.17K to 104.67K | |
| 10-Apr-24 4:30 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 08-Apr-24 | Sale | 3,435 | $11.10 | $38,128.50 | (3%) 100.61K to 97.17K | |
| 22-Jan-24 8:22 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-24 | Sale | 6,307 | $7.75 | $48,900.10 | (6%) 106.92K to 100.61K | |
| 21-Nov-23 4:40 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 20-Nov-23 | Sale | 2,127 | $7.24 | $15,402.70 | (2%) 106.32K to 104.19K | |
| 03-Nov-23 4:55 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Grant | 22,500 | -- | -- | 23% 96.31K to 118.81K | |
| 03-Nov-23 4:55 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Sale | 12,492 | $8.88 | $110,871.00 | (11%) 118.81K to 106.32K | |
| 17-Jul-23 5:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Jul-23 | Grant | 25,000 | $1.00 | $25,000.00 | 35% 71.31K to 96.31K | |
| 05-Jun-23 6:32 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 02-Jun-23 | Sale (Planned) | 1,960 | $11.41 | $22,367.70 | (3%) 70.81K to 68.84K | |
| 23-May-23 12:15 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-May-23 | Sale (Planned) | 2,110 | $12.87 | $27,165.00 | (3%) 72.92K to 70.81K | |
| 07-Apr-23 3:18 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 06-Apr-23 | Sale (Planned) | 3,439 | $7.27 | $25,001.50 | (5%) 76.35K to 72.92K | |
| 03-Mar-23 10:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Mar-23 | Sale (Planned) | 2,032 | $8.53 | $17,334.80 | (3%) 78.39K to 76.35K | |
| 20-Jan-23 7:32 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-23 | Grant | 33,000 | -- | -- | 73% 45.39K to 78.39K | |
| 23-Nov-22 4:10 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Nov-22 | Sale | 2,159 | $9.60 | $20,726.40 | (5%) 45.84K to 43.68K | |
| 02-Sep-22 4:05 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Sep-22 | Grant | 7,500 | -- | -- | 20% 38.34K to 45.84K | |
| 20-May-22 5:17 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-22 | Grant | 12,000 | -- | -- | 46% 26.0K to 38.0K | |
| 16-May-22 8:43 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 13-May-22 | Purchase | 6,000 | -- | -- | 30% 20.0K to 26.0K | |
| 06-Apr-22 8:50 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 05-Apr-22 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 02-Feb-22 4:34 PM View: | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Exercise | 666 | -- | -- | 14% 4.91K to 5.58K | |
| 02-Feb-22 4:34 PM View: | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Sale | 331 | $7.58 | $2,508.98 | (6%) 5.58K to 5.25K | |
| 02-Dec-21 1:15 PM View: | Urogen Pharma Ltd. (URGN) | 30-Nov-21 | Option Exercise | 5,000 | -- | -- | 200% 2.5K to 7.5K | |
| 02-Dec-21 1:15 PM View: | Urogen Pharma Ltd. (URGN) | 30-Nov-21 | Market Option Sale | 2,587 | $12.03 | $31,121.60 | (34%) 7.5K to 4.91K | |
| 18-May-21 11:36 AM View: | Urogen Pharma Ltd. (URGN) | 17-May-21 | Market Purchase | 2,500 | $15.85 | $39,625.00 | 100% 0 to 2.5K | < 1% |
| 11-Apr-19 12:11 PM View: | Advaxis Inc. (ADXS) | 11-Apr-19 | Grant | 2,500 | $3.68 | $9,199.75 | 75% 3.33K to 5.83K | (82%) |
| 10-Apr-19 9:12 AM View: | Advaxis Inc. (ADXS) | 09-Apr-19 | Grant | 3,000 | $3.86 | $11,578.70 | (103%) (-2.9K) to 100 | (83%) |
| 13-Jun-18 6:37 PM View: | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 5,000 | $1.89 | $9,450.00 | 100% 0 to 5.0K | (98%) |
| 21-Jun-12 4:46 PM View: | Virtualscopics, Inc. (VSCP) | 19-Jun-12 | Market Purchase | 8,000 | $0.90 | $7,200.00 | 125% 6.4K to 14.4K | (61%) |
| 17-Mar-08 3:59 PM View: | Virtualscopics, Inc. (VSCP) | 14-Mar-08 | Market Purchase | 6,440 | $0.68 | $4,379.20 | 100% 0 to 6.44K | (2%) |